Combinatorial technology revitalized by DNA-encoding.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 481, doi. 10.1002/mco2.84
- By:
- Publication type:
- Article
Works matching IS 26882663 AND DT 2021 AND VI 2 AND IP 3
Results: 12
1
2
Demethylzeylasteral inhibits proliferation, migration, and invasion through FBXW7/c-Myc axis in gastric cancer.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 467, doi. 10.1002/mco2.73
- By:
- Publication type:
- Article
3
Lomerizine 2HCl inhibits cell proliferation and induces protective autophagy in colorectal cancer via the PI3K/Akt/mTOR signaling pathway.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 453, doi. 10.1002/mco2.83
- By:
- Publication type:
- Article
4
Potent neutralizing RBD-specific antibody cocktail against SARS-CoV-2 and its mutant.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 442, doi. 10.1002/mco2.79
- By:
- Publication type:
- Article
5
A bivalent recombinant vaccine targeting the S1 protein induces neutralizing antibodies against both SARS-CoV-2 variants and wild-type of the virus.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 430, doi. 10.1002/mco2.72
- By:
- Publication type:
- Article
6
Histone lysine demethylase 4B regulates general and unique gene expression signatures in hypoxic cancer cells.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 414, doi. 10.1002/mco2.85
- By:
- Publication type:
- Article
7
The emerging role of neutrophils in autoimmune-associated disorders: effector, predictor, and therapeutic targets.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 402, doi. 10.1002/mco2.69
- By:
- Publication type:
- Article
8
Application of omics technology to combat the COVID-19 pandemic.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 381, doi. 10.1002/mco2.90
- By:
- Publication type:
- Article
9
Current therapeutic strategies for respiratory diseases using mesenchymal stem cells.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 351, doi. 10.1002/mco2.74
- By:
- Publication type:
- Article
10
Two novel strategies to overcome the resistance to ALK tyrosine kinase inhibitor drugs: Macrocyclic inhibitors and proteolysis-targeting chimeras.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 341, doi. 10.1002/mco2.42
- By:
- Publication type:
- Article
11
Molecular mechanisms of chemo- and radiotherapy resistance and the potential implications for cancer treatment.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 315, doi. 10.1002/mco2.55
- By:
- Publication type:
- Article
12
Themultifaceted involvement of exosomes in tumor progression: Induction and inhibition.
- Published in:
- MedComm, 2021, v. 2, n. 3, p. 297, doi. 10.1002/mco2.49
- By:
- Publication type:
- Article